<![CDATA[A 19-year-old female student presented to the university clinic following a hospital diagnosis of grade 1 fatty liver disease. She exhibits grade 2 obesity, dyslipidemia, hyperuricemia, and elevated liver transaminases, with a family history of obesity and type 2 diabetes mellitus. Given the patient's challenges in adhering to diet and exercise recommendations, this evidence-based care report explores whether behavioral interventions, compared with standard care, more effectively improve outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) among young adults. A literature search conducted via PubMed® and Scopus® on June 23, 2026 identified three systematic reviews, three randomized controlled trials, and one cohort study relevant to the clinical inquiries. Findings consistently show that behavioral interventions outperform standard care in weight management, reduction of liver enzymes, and improvements in lipid profiles, though results for lipid changes remain heterogeneous. One study with a three-year follow-up demonstrated improvements in the hepatic steatosis index (HSI) and fatty liver index (FLI), suggesting long-term benefits. Evidence further highlights the role of eHealth strategies, including mobile applications and adherence reminders, in sustaining lifestyle changes. Overall, structured behavioral programs supported by professional coaching and digital monitoring yield significant clinical benefits for young adults with MASLD.]]>
